On Monday, October 19, I'll be moderating a panel on Strategic Considerations for Navigating a Dual-track M&A and Initial Public Offering Pathway at the Association of Corporate Counsel's Annual Conference here in Boston. I'll be joined on the panel by Pete Zorn, Esq., VP of Corporate Development and General Counsel of Albireo Pharma; Stan Piekos, former CFO of NEXX Systems; and Joe Ferra, Managing Director in the Healthcare Investment Banking Group at JMP Securities. If you're attending the ACC conference, we hope you can join us that day at 4:30 for what we expect will be a great discussion.
We'll be covering the do's and don'ts, from a legal and business standpoint, when maximizing the potential value for your company by simultaneously pursuing an M&A exit and an IPO. Our experienced panelists will discuss their practical tips and strategies for companies who are taking on this challenging, yet potentially very rewarding, exit strategy. If you can't attend the conference, some additional information on this topic is in the video at the link below.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
